Mylan Settles Kentucky Drug-Pricing Suit For $6.5M
Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc. have agreed to pay $6.5 million to settle claims that they defrauded Kentucky's Medicaid program by lying about average wholesale prices for their drugs,...To view the full article, register now.
Already a subscriber? Click here to view full article